Searching News Database: Lannett
HSMN NewsFeed - 4 Mar 2022
Lannett Announces Sale of Liquid Drug Manufacturing Plant and Other Assets for $10.5 Million
Lannett Announces Sale of Liquid Drug Manufacturing Plant and Other Assets for $10.5 Million
HSMN NewsFeed - 9 Feb 2021
Lannett Expands Strategic Relationship To Include Biosimilar Fast-Acting Insulin
Lannett Expands Strategic Relationship To Include Biosimilar Fast-Acting Insulin
HSMN NewsFeed - 3 Nov 2020
Lannett Launches Authorized Generic of Tirosint(R) (Levothyroxine Sodium Capsules)
Lannett Launches Authorized Generic of Tirosint(R) (Levothyroxine Sodium Capsules)
HSMN NewsFeed - 17 Aug 2020
Lannett Signs Agreement To Be Exclusive Distributor Of Generic Flovent(R) Diskus(R)
Lannett Signs Agreement To Be Exclusive Distributor Of Generic Flovent(R) Diskus(R)
HSMN NewsFeed - 11 Jun 2020
Lannett Provides Update On Clinical Advancement Of Biosimilar Insulin Glargine, Following FDA Meeting
Lannett Provides Update On Clinical Advancement Of Biosimilar Insulin Glargine, Following FDA Meeting
HSMN NewsFeed - 23 Dec 2019
Lannett Receives FDA Approvals For Two Dosage Strengths Of Butalbital, Acetaminophen And Caffeine Capsules
Lannett Receives FDA Approvals For Two Dosage Strengths Of Butalbital, Acetaminophen And Caffeine Capsules
HSMN NewsFeed - 28 Jun 2019
Lannett Enters Into Distribution Agreement For Dantrolene Capsules, Commences Product Launch
Lannett Enters Into Distribution Agreement For Dantrolene Capsules, Commences Product Launch
HSMN NewsFeed - 30 Apr 2019
Lannett To Launch Generic Concerta(R), AB-rated Methylphenidate Hydrochloride ER Tablets
Lannett To Launch Generic Concerta(R), AB-rated Methylphenidate Hydrochloride ER Tablets
HSMN NewsFeed - 27 Mar 2019
Lannett Receives FDA Approval For Aspirin And Extended-Release Dipyridamole Capsules, 25 mg/200 mg
Lannett Receives FDA Approval For Aspirin And Extended-Release Dipyridamole Capsules, 25 mg/200 mg
HSMN NewsFeed - 12 Nov 2018
Lannett Enters Into Agreement With Amneal Pharmaceuticals For Levothyroxine
Lannett Enters Into Agreement With Amneal Pharmaceuticals For Levothyroxine
HSMN NewsFeed - 20 Aug 2018
Lannett Provides Update On Contract Renewal With Jerome Stevens Pharmaceuticals
Lannett Provides Update On Contract Renewal With Jerome Stevens Pharmaceuticals
HSMN NewsFeed - 29 Jun 2018
Amneal Announces Favorable Ruling Regarding Patent Validity for Zomig(R) (zolmitriptan) Nasal Spray
Amneal Announces Favorable Ruling Regarding Patent Validity for Zomig(R) (zolmitriptan) Nasal Spray
HSMN NewsFeed - 1 Jun 2018
Lannett Receives FDA Approval For Levofloxacin Oral Solution; Imminent Launch Anticipated
Lannett Receives FDA Approval For Levofloxacin Oral Solution; Imminent Launch Anticipated
HSMN NewsFeed - 20 Apr 2018
Lannett Names Maureen Cavanaugh Senior Vice President And Chief Commercial Operations Officer
Lannett Names Maureen Cavanaugh Senior Vice President And Chief Commercial Operations Officer
HSMN NewsFeed - 30 Oct 2017
Lannett And Celgene Enter Into Settlement And License Agreement Related To Thalomid(R)
Lannett And Celgene Enter Into Settlement And License Agreement Related To Thalomid(R)
HSMN NewsFeed - 14 Jul 2017
Lannett Receives Approval For Cyproheptadine Hydrochloride Syrup, 2 mg/5 mL
Lannett Receives Approval For Cyproheptadine Hydrochloride Syrup, 2 mg/5 mL
HSMN NewsFeed - 16 Jun 2017
Lannett Announces Approval For Amantadine Hydrochloride Capsules USP, 100 mg
Lannett Announces Approval For Amantadine Hydrochloride Capsules USP, 100 mg
HSMN NewsFeed - 27 Jan 2017
Pharmaceuticals Veteran George R. Stevenson Joins the GeneriCo Board of Directors
Pharmaceuticals Veteran George R. Stevenson Joins the GeneriCo Board of Directors
HSMN NewsFeed - 20 Sep 2016
Lannett Announces Approval For Buprenorphine And Naloxone Sublingual Tablets, 2 mg/0.5 mg And 8 mg/2 mg
Lannett Announces Approval For Buprenorphine And Naloxone Sublingual Tablets, 2 mg/0.5 mg And 8 mg/2 mg
HSMN NewsFeed - 22 Feb 2016
Lannett Receives FDA Approval For Sumatriptan Nasal Spray USP, 5mg And 20mg
Lannett Receives FDA Approval For Sumatriptan Nasal Spray USP, 5mg And 20mg
HSMN NewsFeed - 27 Nov 2015
Lannett Completes Major Acquisition Of Kremers Urban Pharmaceuticals For $1.23 Billion
Lannett Completes Major Acquisition Of Kremers Urban Pharmaceuticals For $1.23 Billion
HSMN NewsFeed - 8 May 2009
Lannett Company Receives FDA Approval for Pilocarpine HCI Tablets 7.5 mg Strength
Lannett Company Receives FDA Approval for Pilocarpine HCI Tablets 7.5 mg Strength
HSMN NewsFeed - 24 Apr 2008
Lannett Company Receives Approval for Dipyridamole Tablets USP, 25 mg, 50 mg, and 75 mg
Lannett Company Receives Approval for Dipyridamole Tablets USP, 25 mg, 50 mg, and 75 mg
HSMN NewsFeed - 28 Mar 2008
Lannett Company Receives FDA Approval for Bethanechol Chloride Tablets USP, 5 mg, 10 mg, 25 mg, and 50 mg
Lannett Company Receives FDA Approval for Bethanechol Chloride Tablets USP, 5 mg, 10 mg, 25 mg, and 50 mg
HSMN NewsFeed - 10 Oct 2007
Lannett Company Comments on Recent FDA Announcement for Levothyroxine Sodium
Lannett Company Comments on Recent FDA Announcement for Levothyroxine Sodium
Additional items found! 26
Members Archive contains
26 additional stories matching:
Lannett
(Password required)
Lannett
(Password required)